REXLEMESTROCEL-L
UNII 4LS0IJZ59V

Substance Identification & Data

This profile provides standardized clinical and technical data for Rexlemestrocel-l, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4LS0IJZ59V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2172954-10-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
4LS0IJZ59V
CAS Registry Number
2172954-10-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
REXLEMESTROCEL-L
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
USAN ID
BC-132
Identifier assigned by the United States Adopted Names Council.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
ITIS TSN
180092
Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.
NCBI Taxonomy
9606
Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rexlemestrocel-l. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ALLOGENEIC HUMAN BONE MARROW-DERIVED MPC
ALLOGENEIC MESENCHYMAL PRECURSOR CELL
IMMUNOSELECTED STRO-3+ ALLOGENIC MESENCHYMAL PRECURSOR CELLS
REXLEMESTROCEL-L
REXLEMESTROCEL-L [USAN]
REXLEMESTROCEL-L [WHO-DD]

Brand / Trade Names

NEOFUSE
REVASCOR